These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ASO Author Reflections: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer. Satyananda V; Oshi M; Endo I; Takabe K Ann Surg Oncol; 2021 Nov; 28(12):7366-7367. PubMed ID: 33966141 [No Abstract] [Full Text] [Related]
5. Cycling with BRCA2 from DNA repair to mitosis. Lee H Exp Cell Res; 2014 Nov; 329(1):78-84. PubMed ID: 25447315 [TBL] [Abstract][Full Text] [Related]
11. The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis. Haber DA Cell; 2003 Nov; 115(5):507-8. PubMed ID: 14651841 [TBL] [Abstract][Full Text] [Related]
12. A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. Nomizu T; Matsuzaki M; Katagata N; Kobayashi Y; Sakuma T; Monma T; Saito M; Watanabe F; Midorikawa S; Yamaguchi Y Breast Cancer; 2015 Sep; 22(5):557-61. PubMed ID: 23242612 [TBL] [Abstract][Full Text] [Related]
13. Unique divergence of the breast cancer 2 ( Michalak P; Kang L Hereditas; 2018; 155():34. PubMed ID: 30410429 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation. Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164 [TBL] [Abstract][Full Text] [Related]
15. Identification and purification of a soluble region in the breast cancer susceptibility protein BRCA2. Finch D; Webb M Protein Expr Purif; 2005 Mar; 40(1):177-82. PubMed ID: 15721786 [TBL] [Abstract][Full Text] [Related]
16. BRCA2 gene mutation in cancer. Xie C; Luo J; He Y; Jiang L; Zhong L; Shi Y Medicine (Baltimore); 2022 Nov; 101(45):e31705. PubMed ID: 36397405 [TBL] [Abstract][Full Text] [Related]
17. BRCA2 mutations and triple-negative breast cancer. Meyer P; Landgraf K; Högel B; Eiermann W; Ataseven B PLoS One; 2012; 7(5):e38361. PubMed ID: 22666503 [TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis. Forat-Yazdi M; Neamatzadeh H; Sheikhha MH; Zare-Shehneh M; Fattahi M Asian Pac J Cancer Prev; 2015; 16(3):1219-24. PubMed ID: 25735359 [TBL] [Abstract][Full Text] [Related]
20. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Jonkers J; Meuwissen R; van der Gulden H; Peterse H; van der Valk M; Berns A Nat Genet; 2001 Dec; 29(4):418-25. PubMed ID: 11694875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]